<![CDATA[Genmab — September 2021]]>God morgen. 🙂

]]>https://dev.proinvestor.com/forum/topic/399152/genmab-september-2021RSS for NodeTue, 09 Jun 2026 08:10:47 GMTWed, 01 Sep 2021 02:23:42 GMT60<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 16:14:02 GMT]]>GMAB (og USD/DKK) sniger sig langsomt op - pt. 2835 DKK

]]>https://dev.proinvestor.com/forum/post/7644936https://dev.proinvestor.com/forum/post/7644936Thu, 30 Sep 2021 16:14:02 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 15:31:18 GMT]]>Hemlibra ser ud til at blive indsprøjtet subcutant 1 gang om ugen de første 4 uger, derefter afpasset efter behov - ud fra deres website takinghemlibra.com ser det ud til at være med kanyle, mens der lægges op til muligheden for pen device med mim8 pga den stærkt begrænsede mægde, der er behov for (https://ashpublications.org/blood/article/134/Supplement_1/96/424445/Mim8-a-Next-Generation-FVIII-Mimetic-Bi-Specific) Det kunne godt have en betydning, hvis hemlibra ikke kan gives med pen...

]]>https://dev.proinvestor.com/forum/post/7644934https://dev.proinvestor.com/forum/post/7644934Thu, 30 Sep 2021 15:31:18 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 15:20:05 GMT]]>Nemmerlig.

]]>https://dev.proinvestor.com/forum/post/7644935https://dev.proinvestor.com/forum/post/7644935Thu, 30 Sep 2021 15:20:05 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 14:47:07 GMT]]>Så er der kun prisen at konkurrere på......

]]>https://dev.proinvestor.com/forum/post/7644932https://dev.proinvestor.com/forum/post/7644932Thu, 30 Sep 2021 14:47:07 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 14:35:13 GMT]]>Hvis Hemlibra gør jobbet, hvorfor skulle det så være interessant med et stof der 100x så potent ? De kan jo også betyde bivirkninger x100

]]>https://dev.proinvestor.com/forum/post/7644928https://dev.proinvestor.com/forum/post/7644928Thu, 30 Sep 2021 14:35:13 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 14:24:07 GMT]]>Tolker man ikke af overskriften, at Roche "vinder" fordi de er først i markedet og Novo for svært ved. at tilbageerobre (fra overskriften) markedet trods et "måske" bedre produkt. Det kunne også være en presset herre, der ser, at deres vinder bliver banket på plads i en nær fremtid?

]]>https://dev.proinvestor.com/forum/post/7644933https://dev.proinvestor.com/forum/post/7644933Thu, 30 Sep 2021 14:24:07 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 14:21:54 GMT]]>Hvad mener han med “på papiret bedre”, men åbenbart ikke i virkelighedens verden?

]]>https://dev.proinvestor.com/forum/post/7644931https://dev.proinvestor.com/forum/post/7644931Thu, 30 Sep 2021 14:21:54 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 14:19:43 GMT]]>Men det havde været rart, at kunne se argumenterne.

]]>https://dev.proinvestor.com/forum/post/7644927https://dev.proinvestor.com/forum/post/7644927Thu, 30 Sep 2021 14:19:43 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 14:18:01 GMT]]>Måske siger han det bare, fordi det skal han jo sige.

]]>https://dev.proinvestor.com/forum/post/7644930https://dev.proinvestor.com/forum/post/7644930Thu, 30 Sep 2021 14:18:01 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 14:03:36 GMT]]>Strange comment from Roche. Jan told us
several times that Mim8 is 100 times more potent than Hemlibra!

]]>https://dev.proinvestor.com/forum/post/7644926https://dev.proinvestor.com/forum/post/7644926Thu, 30 Sep 2021 14:03:36 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 12:55:02 GMT]]>maybe in the Novo page someone has seen it

]]>https://dev.proinvestor.com/forum/post/7644924https://dev.proinvestor.com/forum/post/7644924Thu, 30 Sep 2021 12:55:02 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 12:40:47 GMT]]>Here in Danish, that someone might have acces to https://finans.dk/erhverv/ECE13319485/storrival-affejer-novo-som-trussel-paa-lukrativt-bloedermarked-det-er-meget-svaert-at-slaa/

]]>https://dev.proinvestor.com/forum/post/7644921https://dev.proinvestor.com/forum/post/7644921Thu, 30 Sep 2021 12:40:47 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 12:24:19 GMT]]>no , surely someone else can?

]]>https://dev.proinvestor.com/forum/post/7644923https://dev.proinvestor.com/forum/post/7644923Thu, 30 Sep 2021 12:24:19 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 11:47:49 GMT]]>can you read the rest?

]]>https://dev.proinvestor.com/forum/post/7644925https://dev.proinvestor.com/forum/post/7644925Thu, 30 Sep 2021 11:47:49 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 11:40:49 GMT]]>Roche dismisses Novo Nordisk as potential threat on lucrative hemophilia market https://medwatch.com/News/Pharma___Biotech/article13328369.ece

]]>https://dev.proinvestor.com/forum/post/7644917https://dev.proinvestor.com/forum/post/7644917Thu, 30 Sep 2021 11:40:49 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 11:28:55 GMT]]>Ugekommentar #12 Uro på aktiemarkedet - Hvad sker der? https://www.proinvestor.com/index.php?p=debat_1&postid=97416

]]>https://dev.proinvestor.com/forum/post/7644918https://dev.proinvestor.com/forum/post/7644918Thu, 30 Sep 2021 11:28:55 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 08:59:08 GMT]]>Så er det i morgen kl 14 da ti (så vidt jeg kan regne ud) at der er SITC Regular abstract titles https://www.sitcancer.org/2021/abstracts/abstract-information

]]>https://dev.proinvestor.com/forum/post/7644920https://dev.proinvestor.com/forum/post/7644920Thu, 30 Sep 2021 08:59:08 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 08:33:37 GMT]]>Det er gået stærkt ned ad bakke for c25 igen i dag. Men Genmab ligger faktisk nr 1 på hitlisten.

]]>https://dev.proinvestor.com/forum/post/7644919https://dev.proinvestor.com/forum/post/7644919Thu, 30 Sep 2021 08:33:37 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 07:34:17 GMT]]>yes, that is why is said earlier, peak annual sales are a bit lol, i don't get. They either have not yet incorporated EU sales at all, or they made a mistake in their write up.

]]>https://dev.proinvestor.com/forum/post/7644915https://dev.proinvestor.com/forum/post/7644915Thu, 30 Sep 2021 07:34:17 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 07:25:33 GMT]]>In your quote 9:49 it says $3,5 bn globally.

]]>https://dev.proinvestor.com/forum/post/7644922https://dev.proinvestor.com/forum/post/7644922Thu, 30 Sep 2021 07:25:33 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 07:21:11 GMT]]>i am not complaining 😉 . but it clearly say peak ** U.S. ** annual net sales of >$3B. which seems realistic given that they intend to make >$1.55 Bn already in '21 in the US only

]]>https://dev.proinvestor.com/forum/post/7644914https://dev.proinvestor.com/forum/post/7644914Thu, 30 Sep 2021 07:21:11 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 07:11:29 GMT]]>And we are talking about an antibody that was long forgotten a few years ago.

]]>https://dev.proinvestor.com/forum/post/7644911https://dev.proinvestor.com/forum/post/7644911Thu, 30 Sep 2021 07:11:29 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 07:07:15 GMT]]>But not bad. Means 1,3 bn DKK in royalty (6%).

]]>https://dev.proinvestor.com/forum/post/7644912https://dev.proinvestor.com/forum/post/7644912Thu, 30 Sep 2021 07:07:15 GMT<![CDATA[Reply to Genmab — September 2021 on Thu, 30 Sep 2021 06:51:12 GMT]]>Then if annual global net sales exceeds $3,5, it means that the 3 bn is for both US and Europe.

]]>https://dev.proinvestor.com/forum/post/7644909https://dev.proinvestor.com/forum/post/7644909Thu, 30 Sep 2021 06:51:12 GMT